The <1 kDa fraction, in particular, which displayed significant ACE-inhibitory and antioxidant activities, could be considered a particularly promising candidate for further development as a multifunctional therapeutic agent for hypertension and oxidative stress-related conditions. The gene discussed is ACE; the disease is Hypertension.